Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Natrecor

 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Nesiritide
Nesiritide 1.5 MG Injection [Natrecor]Nesiritide Injection [Natrecor]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Readmissions and Diuretic Dosing.
  • H. Peled
  • JACC. Heart failure
  • 2017
    • Corpus ID: 205771905
Sud et al. [(1)][1] do an amazing job of examining factors associated with readmission and length of stay “with the aim of… Expand
2016
2016
Revisiting Nesiritide (Natrecor) in Group 2 Pulmonary Hypertension
 
2011
2011
In brief: nesiritide (Natrecor).
  • The Medical letter on drugs and therapeutics
  • 2011
    • Corpus ID: 41890882
 
2006
2006
The rise and fall of Natrecor for congestive heart failure: implications for drug policy.
Recent revelations of unexpected side effects of widely prescribed medications have raised questions about several aspects of U.S… Expand
2006
2006
Nesiritide (Natrecor) for Acute Decompensated Heart Failure
Nesiritide improves short-term hemodynamics in hospitalized patients with acute decompensated heart failure who have not… Expand
2006
2006
Drug usage evaluation: Nesiritide (Natrecor®)
Third Place winner of poster presentations at the 2nd Annual Symposium on Graduate Research and Scholarly Projects (GRASP) held… Expand
  • table 1
2005
2005
Limit Natrecor to hospital use, say experts.
  • Harvard heart letter : from Harvard Medical…
  • 2005
    • Corpus ID: 44537508
 
2004
2004
1049-112 Utility of B-type natriuretic peptide and ProBNP in evaluation of patients receiving natrecor therapy (UBET study)
 
Review
2003
Review
2003
Nesiritide (Natrecor): a new treatment for acutely decompensated congestive heart failure.
The care of the patient experiencing acutely decompensated congestive heart failure requires therapies that promote vasodilation… Expand
Highly Cited
1999
Highly Cited
1999
Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.
OBJECTIVES The goal of this study was to further define the role of nesiritide (human b-type natriuretic peptide) in the therapy… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE